| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 135168 | Null | 0.00415749398947839 | -0.10080894 |
| NSC 702655 | Null | 0.00415749398947839 | -0.046888747 |
| NSC 715722 | Null | 0.00415749398947839 | 0.2008623 |
| NSC 726112 | 12-(4'-Phthalimidobutylidene)-5,6-dihydro-5,11-diketo-2,3-di methoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquin oline | 0.00415749398947839 | 0.2340909 |
| NSC 760183 | tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | 0.00415749398947839 | 0.18041778 |
| NSC 621888 | Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) | 0.00415749398947845 | 0.60134736 |
| NSC 668261 | Null | 0.00415749398947845 | 0.45675398 |
| NSC 704888 | Fumaric acid, 2-[5-chloro-3-(2-ethoxy-2-oxoethyl)-2,4-dioxo- 1H,3H-pyrimidinyl]-, diethyl ester | 0.00423163567577548 | 0.53622497 |
| NSC 707465 | 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- | 0.00423163567577548 | 0.48978051 |
| NSC 708419 | Null | 0.00423163567577548 | 0.2839417 |